Indian J Med Sci About us | Subscription  |  Top cited articles | Contact Us | Feedback | Login   
Print this page Email this page   Small font size Default font size Increase font size 
 Users Online : 67
Home Current Issue Ahead of print Back Issues  Instructions Search e-Alerts
  Navigate here 
  Search
 
 ¤  Next article
 ¤  Previous article 
 ¤  Table of Contents
  
 Resource links
 ¤   Similar in PUBMED
 ¤  Search Pubmed for
 ¤  Search in Google Scholar for
 ¤   [PDF Not available] *
 ¤   Citation Manager
 ¤   Access Statistics
 ¤   Reader Comments
 ¤   Email Alert *
 ¤   Add to My List *
* Registration required (free)  


  In this article

 Article Access Statistics
    Viewed194    
    Printed23    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 


 
BOOK REVIEW
Year : 1995  |  Volume : 49  |  Issue : 2  |  Page : 35
 

Book Review-1


,

Correspondence Address:
D D Banker
,

Login to access the Email id


Get Permissions



How to cite this article:
Banker D D. Book Review-1. Indian J Med Sci 1995;49:35

How to cite this URL:
Banker D D. Book Review-1. Indian J Med Sci [serial online] 1995 [cited 2013 Jun 19];49:35. Available from: http://www.indianjmedsci.org/text.asp?1995/49/2/35/57833


IARC MONOGRAPH ON THE EVA­LUATION OF CARCINOGENIC RISKS TO HUMANS - VOLUME 59 - HEPATITIS VIRUSES. - International Agency for Rese­arch on Cancer, World Health Organization, Lyon, France 1994, pp. 286. Price SW.F.65.

In 1969, the IARC initiated a programme on the evaluation of the carcinogenic risk of chemicals to humans. Later the programme was expanded to include complex mixtures and other agents. The monographs are prepared with the help of international experts. This monograph deals with three human hepatotropic viruses which can have a chronic course, namely hepatitis B (HBV), C (HCV) and D (HDV). Chronic infection with HBV is prevalent in many human populations, particularly in deve­loping countries, to the extent that over 300 million are affected world­wide. The global incidence of primary cancer of the liver was estimated at about 300,000 cases in 1985. Regarding HCV, 0.5-2% of people in most parts of the world have serological evidence o~ past or current infection. Acute infection leads to chronic liver disease in about 50% of sympto­matic patients. HDV requires the presence of genetic information from HBsAg for its replication and is hence closely associated with HBV infection. The monograph has included for each of the three viruses the structure and biologi­cal data, epidemiology, clinical features and studies on liver can­cer in humans. Numerous referen­ces have been provided. The final evaluation is that there is sufficient evidence to establish carcinogeni­city of HBV and HCV among humans, while for HDV the evi­dence available is insufficient. The monograph will be useful for those engaged in research on hepatic cancer.




 

Top
Print this article  Email this article
Previous article Next article

    

© 2004 - Indian Journal of Medical Sciences
Published by Medknow
Online since 15th December '04